dQ&A is announcing the availability of new data collected this quarter from ten thousand people with diabetes in the USA, Canada and seven EU countries.
dQ&A presented three research abstracts at ATTD 2025, an academic and professional conference of innovation and advancement in diabetes devices.
Our research reveals low awareness of DKA and ketone testing among type 2 diabetes patients on SGLT2 inhibitors, highlighting urgent education needs.